Published 7 months ago • loading... • Updated 7 months ago

AnX Robotica Announces FDA 510(k) Clearance for MotiliCap™ and MotiliScan™: Next-Generation GI Motility Monitoring Solutions

AnX Robotica announced FDA 510 clearance for MotiliCap and MotiliScan on May 27, 2025, in Plano, Texas, offering new GI motility monitoring tools.
The clearance follows the discontinuation of SmartPill and the need for advanced, non-invasive devices to assess whole-gut transit times accurately.
MotiliCap is an advanced motility capsule that monitors digestive tract movement throughout the stomach, small intestine, and large intestine, with collected data integrated into MotiliScan software for comprehensive analysis.
MotiliScan allows healthcare providers to monitor variations in pH levels, pressure, and temperature, offers customizable reports focused on specific GI segments, and facilitates quicker recognition of motility disorders to support timely treatment choices.
This FDA clearance represents a significant advance in GI diagnostics, providing clinicians with a comprehensive, patient-friendly solution that enhances diagnostic speed and accuracy.

Insights by Ground AI

15 Articles

Farm Talk Newspaper

+14 Reposted by 14 other sources

Center

AnX Robotica Announces FDA 510(k) Clearance for MotiliCap™ and MotiliScan™: Next-Generation GI Motility Monitoring Solutions

PLANO, Texas, May 27, 2025 /PRNewswire/ -- AnX Robotica, a leader in advanced gastrointestinal diagnostic solutions, is proud to announce the FDA 510(k) clearance of MotiliCap™ and its companion software, MotiliScan™. This latest clearance marks a significant step forward in…

7 months ago·Parsons, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year